Molnupiravir reduces risk of hospitalization and death in patients with mild to moderate COVID-19
Update: 2025-10-12
Description
Merck is looking for Emergency Use Authorization from the US Food and Drug Administration……for its oral antiviral molnupiravir (mol-new-peer-ih-vir).Merck and Ridgeback Biotherapeutics report that in their phase three clinical trial……the medication cut the risk of hospitalization and death f....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Columbia Peaks, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
